Loading...
 
Toggle Health Problems and D

Fracture risk 40 percent higher risk if low Vitamin D - June 2019

J Bone Miner Res. 2019 Jun 24. doi: 10.1002/jbmr.3818
Zhu K1,2, Lewis JR2,3,4, Sim M2,3, Prince RL1,2.
1 Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Perth, WA, Australia.
2 Medical School, University of Western Australia, Perth, WA, Australia.
3 School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia.
4 Centre for Kidney Research, Children's Hospital at Westmead, School of Public Health, Sydney Medical School,
  The University of Sydney, Sydney, NSW, Australia.

 Download the PDF from sci-hub via VitaminDWiki
Charts of the data from Grassroots Health
Image

Image

The vitamin D debate relates in part to ideal public health population levels of circulating 25-hydroxyvitamin D (25OHD) to maintain bone structure and reduce fracture. In a secondary analysis of 1348 women aged 70 to 85 years at baseline (1998) from the Perth Longitudinal Study of Aging in Women (a 5-year calcium supplementation trial followed by two 5-year extensions), we examined the dose-response relations of baseline plasma 25OHD with hip DXA BMD at year 1, lumbar spine BMD, and trabecular bone score (TBS) at year 5, and fracture-related hospitalizations over 14.5 years obtained by health record linkage. Mean baseline plasma 25OHD was 66.9 ± 28.2 nmol/L and 28.5%, 36.4%, and 35.1% of women had levels <50, 50 to 74.9, and ≥75 nmol/L, respectively. Generalized additive models showed that total hip and femoral neck BMD and TBS, but not spine BMD, were higher with increasing plasma 25OHD up to 100 nmol/L. Compared with those with 25OHD <50 nmol/L, women with 25OHD ≥75 nmol/L had significantly higher total hip and femoral neck BMD at year 1 (3.3% to 3.9%) and TBS at year 5 (2.0%), all P < 0.05.
During the follow-up, 27.6% of women experienced any fracture-related hospitalization and 10.6% hip fracture-related hospitalization. Penalized spline regression models showed a decrease in risk with increased 25OHD levels up to 65 nmol/L and 75 nmol/L for hip fracture and any fracture-related hospitalization, respectively.
Cox regression grouped analyses showed that compared with women with 25OHD <50 nmol/L, those with 25OHD levels 50 to 74.9 and ≥75 nmol/L had significantly lower risk for hip fracture [HR 0.60 (95% CI, 0.40 to 0.91) and 0.61 (95% CI, 0.40 to 0.92), respectively], and any fracture-related hospitalization [HR 0.77 (95% CI, 0.59 to 0.99) and 0.70 (95% CI, 0.54 to 0.91), respectively]. In older white women, 25OHD levels >50 nmol/L are a minimum public health target and 25OHD levels beyond 75 nmol/L may not have additional benefit to reduce fracture risk.


Created by admin. Last Modification: Tuesday August 27, 2019 15:15:42 GMT-0000 by admin. (Version 4)

Attached files

ID Name Comment Uploaded Size Downloads
12554 Fracture risk2 GRH.jpg admin 27 Aug, 2019 64.23 Kb 824
12553 Fracture Risk1 GRH.jpg admin 27 Aug, 2019 141.41 Kb 724
12552 Fracture risk vit d sci-hub.pdf admin 27 Aug, 2019 287.64 Kb 647